Safety and Efficacy of S-1, a Novel Oral Fluorouracil Antitumor Drug, for a Chronic Renal Failure Patient Maintained on Hemodialysis

Publisher： Karger

E-ISSN： 1423-0232|66|5|358-364

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.5, 2004-09, pp. : 358-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Irinotecan in a Patient with Metastatic Colorectal Cancer on Hemodialysis due to Chronic Renal Failure

By  

Oncology Research and Treatment, Vol. 25, Iss. 1, 2002-03 ,pp. : 60-63

Karger

Access to resources Recommend Favorite

Prevention of Peritoneal Metastasis of Human Gastric Cancer Cells in Nude Mice by S-1, a Novel Oral Derivative of 5-Fluorouracil

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 176-182

Karger

Access to resources Recommend Favorite

Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 191-197

Karger

Access to resources Recommend Favorite

Innate Antiviral Immunity Is Not Impaired in Patients with Chronic Renal Failure on Hemodialysis

By  

Nephron Clin Pract, Vol. 101, Iss. 4, 2005-08 ,pp. : c207-c210

Karger

Access to resources Recommend Favorite

Linear IgA bullous dermatosis in a diabetic patient with chronic renal failure

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 41, Iss. 11, 2002-11 ,pp. : 778-780

John Wiley & Sons Inc

Access to resources Recommend Favorite